Skip to main content

Nifty range-bound, internals still leaking — not a dip to trust

Decliners beat advancers again, Stage-2 cohort shrinking, and 70 stocks left Stage 2 in five days.

Monday, 7 September 20262 min readStage2Stocks Market Desk

Nifty 50
23,779
-0.5% on the day
Market
Neutral — Fading
5 sessions in this state
Breadth
42%
above 200-DMA · narrow
Adv / Dec
1,031 / 1,461
decliners ahead
52w highs / lows
206 / 163
net +43
Stage-2 share
33%
cohort narrowing

The tape is hollowing out, not consolidating. Nifty 50 sits at 23,779, below its 200-day average and nearly 10% off its 52-week high, and today's -0.5% session is not a buyable dip inside strength — it is another down-day in a market that has been unable to build any momentum for a week. With 70 stocks rotating out of Stage 2 against only 28 entering it over the last five days, the advancing cohort is shrinking, not pausing.

Trajectory: range-bound, but the drift is lower

The six-session continuity series tells a consistent story: the index has not had a single up-day worth noting, decliners have beaten advancers in five of the six sessions, and the fast short-term breadth gauge — the share of stocks above their 20-day average — has oscillated between 36% and 44% without any sustained lift, closing today at 41.6%. The slow structural gauge, stocks above their 200-day average, has slipped from 42.5% to 42% over the same stretch, a modest but unbroken deterioration. Net new highs briefly turned negative mid-week and recovered to only +43 today — thin cover for a market that needs expanding new highs to confirm a real advance. The Stage-2 cohort has contracted by 2.2 over 20 days. This is not a market in a healthy pause; it is one where distribution is quietly outpacing accumulation.

Leadership: defensive and narrow

Health Care led on the day at +0.7% and holds the top spot over both one month and three months, which is a defensive rotation signal, not a growth one. Communication Services added +0.5% on the day and is the only other sector in positive territory. Energy is where the Stage-2 cohort is expanding fastest over the last 20 days, and Asian Energy Services has cleared the screen in both the leading and pullback categories — but a single name in a sector advancing against a deteriorating broader tape is context, not confirmation. The screen is doing its job surfacing setups; the backdrop is the reason to treat each one with scepticism until the advance-decline line and the fast breadth gauge show a cleaner turn.

Leading Stage-2 setups
StockSectorSetup% 1D
Bliss GVS Pharma LtdHealth Care9.8+3.0%
KRN Heat Exchanger and Refrigeration LtdIndustrials9.8+3.0%
Omaxe LtdReal Estate9.6-4.8%
Ratnaveer Precision Engineering LtdIndustrials9.6+0.6%
Asian Energy Services LtdEnergy9.4-1.1%
Apollo Pipes LtdIndustrials9.4-0.7%
Modison LtdIndustrials9.4+1.2%
AVT Natural Products LtdConsumer Staples9.4-1.0%
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Health Care+0.7%+1.5%+11.4%7147%
Communication Services+0.5%+0.7%+10.2%5825%
Consumer Discretionary-0.1%-1.6%+11.7%5935%
Industrials-0.2%-1.1%+5.0%6730%
Financials-0.5%-1.0%+5.2%5933%
Consumer Staples-0.5%-5.4%-1.8%4334%
Utilities-0.6%-4.5%-7.8%5519%
Materials-0.7%-1.5%+2.9%6336%
Energy-0.8%-1.6%+3.3%5845%
Real Estate-1.2%+1.4%+15.4%5528%
Information Technology-1.3%-4.0%+5.6%4427%
Share of NSE stocks in Stage 2Mar 2026 – Sep 2026 · weekly
0%10%20%30%40%50%60%70%Jul 26Nifty 50Stocks in Stage 2Latest: 34%
The share of NSE stocks in Stage 2 over the six months to this wrap, with the Nifty's shape above it: the market underneath the day's numbers. Source: Stage2Stocks classification of every NSE stock with enough history, each week.
Try it on Stage2StocksHow to read this chart Lesson 3 of the course: why the Nifty isn't the market, and what the share of stocks in Stage 2 tells you.

Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

All market wraps →